| Date Filed | Type | Description |
| 09/09/2022 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 08/26/2022 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 08/26/2022 |
8-K
| Quarterly results |
| 08/12/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 08/03/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 07/18/2022 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 06/30/2022 |
8-K
| Quarterly results |
| 06/24/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 06/24/2022 |
8-K
| Quarterly results |
| 06/10/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 06/10/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 06/10/2022 |
8-K
| Quarterly results |
| 06/07/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 06/07/2022 |
8-K
| Quarterly results |
| 06/06/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 06/06/2022 |
8-K
| Quarterly results |
| 05/20/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 05/18/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 05/16/2022 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 05/10/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 05/10/2022 |
8-K
| Quarterly results |
| 05/06/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 04/26/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 04/26/2022 |
8-K
| Investor presentation|
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"MERGER AGREEMENT AND PLAN OF REORGANIZATION BY AND AMONG ISLEWORTH HEALTHCARE ACQUISITION CORP., IHAC FIRST MERGER SUB INC., IHAC SECOND MERGER SUB LLC, ISLEWORTH HEALTHCARE SPONSOR I, LLC ) AND CYTOVIA HOLDINGS, INC. DATED AS OF APRIL 26, 2022",
"Form of Sponsor Support Agreement",
"Form of Stockholder Support Agreement",
"Form of PIPE Subscription Agreement",
"Isleworth Healthcare Acquisition Corp. and Cytovia Therapeutics Announce Agreement for Business Combination to Create Publicly Listed Company Focused on Empowering Natural Killer Cell Therapeutics to Fight Cancer",
"Investor Presentation dated April 2022" |
|
| 03/29/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 02/14/2022 |
SC 13G
| GLAZER CAPITAL, LLC reports a 5.2% stake in Isleworth Healthcare Acquisition Corp. |
| 11/16/2021 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 09/10/2021 |
3
| Reed Monica P (Director) has filed a Form 3 on Isleworth Healthcare Acquisition Corp. |
| 09/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/10/2021 |
8-K
| Quarterly results |
| 08/24/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
| 08/16/2021 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 06/07/2021 |
10-Q
| Quarterly Report for the period ended March 31, 2021 |
| 06/03/2021 |
8-K
| Quarterly results |
|